Anthem Biosciences
ANTHEM · Pharma > Pharmaceuticals & Drugs Listing date: July 21, 2025

Stock Price vs Company Growth
1d
1.5%
1w
2.5%
1m
7.3%
3m
21.5%
all
10.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 651 1.5%
620
873
Company Overview

Sales
1,954 Cr
Growth: 61.0%
Profit after Tax
554 Cr
Growth: 19.7%
Large Cap
36,575 Cr
P/E: 66.7x
Industry P/E: 33.2x
Fundamentals

Sales (Cr) ₹ 1,954
Growth 61.0%
EBITDA 37.1%
P/S 18.8x
Dividend 0.0%
P/E 66.7x
Book Value ₹ 2
PEG Ratio 1.1x
ROE 493.9%
P/B N/A
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

Anthem Biosciences has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. Awards, accreditations, and recognition2023: Received a certificate of recognition as a ‘Four Star Export House’ from the Ministry of Commerce and Industry.
Belongs to (2 Indices)